Research in the Kaeberlein Lab is focused on developing therapies for age-associated diseases by targeting the pathways that regulate aging.
|2016-08-31||Dr. Kaeberlein talks about geroscience and the Dog Aging Project on Southern California Public Radio's AirTalk. Listen to the interview here.|
|2016-08-29||The Dog Aging Project featured in Smithsonian Magazine interview with Daniel Promislow.|
|2016-08-26||"Age-associated vulval integrity is an important marker of nematode healthspan" published in the Journal of the American Aging Association (AGE).|
|2016-08-23||"Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice" published in eLife. Full text here.
|2016-07-19||Interview with Dr. Kaeberlien on DVM360. "Rapamycin: A real fountain of youth?"|
|2016-07-01||"Rapamycin in aging and disease: maximizing efficacy while minimizing side effects" published in Oncotarget.|
|2016-07-01||"New insights into cell non-autonomous mechanisms of the C. elegans hypoxic response" and "New functional and biophysical insights into the mitochondrial Rieske iron-sulfur protein from genetic suppressor analysis in C. elegans" published in Worm.|